IP Library Granted Patent US 7,368,262
Granted Patent B2
US 7,368,262 · App. 10/716,793 · Granted May 6, 2008

Promoter variants for expressing genes in a fungal cell

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,368,262
App. No.
10/716,793
Granted
May 6, 2008
Kind
B2
Abstract

The present invention relates to methods for producing a biological substance, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the biological substance, wherein the fungal host cell comprises a first nucleic acid sequence encoding the biological substance operably linked to a second nucleic acid sequence comprising a promoter variant selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, and SEQ ID NO: 12; and a subsequence thereof; and hybrid and tandem promoters thereof; and (b) isolating the biological substance from the cultivation medium. The present invention also relates to the isolated promoter variants and to constructs, vectors, and fungal host cells comprising the promoter variants operably linked to nucleic acid sequences encoding biological substances.

Claims (21)

1. A method for producing a polypeptide, comprising:

(a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising a promoter variant comprising SEQ ID NO: 5; or a subsequence thereof; or a hybrid or a tandem promoter thereof; wherein the subsequence, the hybrid promoter, or the tandem promoter comprises at least one copy of the sequence CGGCGTAATTTCGGCC (SEQ ID NO: 70); and

(b) isolating the polypeptide from the cultivation medium.

2. The method of claim 1 , wherein the promoter variant comprising SEQ ID NO: 5 increases expression of the first nucleic acid sequence compared to the parent promoter of SEQ ID NO: 1.

3. The method of claim 1 , wherein the hybrid promoter comprises a portion of SEQ ID NO: 3 and a portion of SEQ ID NO: 5, wherein at least one of the portions comprises at least one copy of the sequence CGGCGTAATTTCGGCC (SEQ ID NO: 70).

4. The method of claim 1 , wherein the tandem promoter comprises SEQ ID NO: 3 and SEQ ID NO: 5.

5. The method of claim 3 , wherein both portions of the hybrid promoter comprise at least one copy of the sequence CGGCGTAATTTCGGCC (SEQ ID NO: 70).

6. The method of claim 1 , wherein the fungal host cell contains one or more copies of the first nucleic acid sequence.

7. The method of claim 1 , wherein the fungal host cell contains one copy of the first nucleic acid sequence.

8. The method of claim 1 , wherein the polypeptide is selected from the group consisting of an antigen, enzyme, growth factor, hormone, immunodilator, neurotransmitter, receptor, reporter protein, structural protein, and transcription factor.

9. The method of claim 1 , wherein the polypeptide is native or foreign to the fungal host cell.

10. An isolated promoter variant comprising SEQ ID NO: 5; or a subsequence thereof; or a hybrid or a tandem promoter thereof; wherein the subsequence, the hybrid promoter, or the tandem promoter comprises at least one copy of the sequence CGGCGTAATTTCGGCC (SEQ ID NO: 70).

11. The promoter variant of claim 10 , which increases expression of a nucleic acid sequence encoding a polypeptide compared to the parent promoter of SEQ ID NO: 1.

12. The promoter variant of claim 10 , wherein the hybrid promoter comprises a portion of SEQ ID NO: 3 and a portion of SEQ ID NO: 5, wherein at least one of the portions comprises at least one copy of the sequence CGGCGTAATTTCGGCC (SEQ ID NO: 70).

13. The promoter variant of claim 10 , wherein the tandem promoter comprises SEQ ID NO: 3 and SEQ ID NO: 5.

14. A nucleic acid construct comprising a nucleic acid sequence encoding a polypeptide operably linked to the promoter variant of claim 10 .

15. A recombinant expression vector comprising the nucleic acid construct of claim 14 .

16. A recombinant host cell comprising the nucleic acid construct of claim 14 .

17. A method for producing a polypeptide, comprising (a) cultivating a homologously recombinant cell, having incorporated therein a new transcription unit comprising a promoter variant of claim 10 , an exon, and/or a splice donor site operably linked to a second exon of an endogenous nucleic acid sequence encoding the polypeptide, under conditions conducive for production of the polypeptide; and (b) recovering the polypeptide.

18. The promoter variant of claim 12 , wherein both portions of the hybrid promoter comprise at least one copy of the sequence CGGCGTAATTTCGGCC (SEQ ID NO: 70).

19. The method of claim 11 , wherein the polypeptide is selected from the group consisting of an antigen, enzyme, growth factor, hormone, immunodilator, neurotransmitter, receptor, reporter protein, structural protein, and transcription factor.

Assignments (2)
CHANGE OF NAME Recorded Sep 1, 2005
From: NOVOZYMES, INC.
To: NOVOZYMES, INC.
Reel/Frame 016937/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2004
From: YAVER, DEBBIE; NHAM, PETER
To: NOVOZYMES BIOTECH, INC.
Reel/Frame 015160/0927 →